ADMA | ADMA Biologics Inc 2.14 -0.01 (-0.55%)
Category: Consumer goods
Quick infos Trade prices Volume: Market Cap: Prev closed: Open: High: Low: 52 week low: 52 week high: Dividends:
Earnings History Date EPS / Forecast Revenue / Forecast November 5, 2020 - / -0.19- / 10.46MAugust 5, 2020 -0.23 / -0.167.79M / 10.57MMay 6, 2020 -0.26 / -0.1110.2M / 11.34MMarch 12, 2020 -0.18 / -0.1712.04M / 10.42MBeat! November 6, 2019 -0.19 / -0.217.22M / 5.77MBeat! view more
Historical Data Date Price Open High Low Vol Change ER Dec 11, 2020 2.06 2.20 2.23
2.05
3.39M -5.94% Dec 10, 2020 2.19 2.17 2.31
2.10
5.20M -1.35% Dec 9, 2020 2.22 2.23 2.36
2.11
13.45M 6.22% Dec 8, 2020 2.09 1.97 2.20
1.92
10.63M 6.63% Dec 7, 2020 1.96 2.02 2.02
1.94
2.48M -2% Dec 4, 2020 2.00 1.98 2.03
1.95
2.23M 1.52% Dec 3, 2020 1.97 1.99 2.01
1.93
2.10M -1.01% Dec 2, 2020 1.99 1.99 2.00
1.93
1.75M -1% Dec 1, 2020 2.01 2.04 2.12
1.97
2.48M -1.47% Nov 30, 2020 2.04 1.95 2.05
1.90
4.00M 7.37% view more
News
Volatile action in ADMA Biologics as Jefferies talks takeout seekingalpha.com Oct 1, 2020 12:14 am Adma Biologics up 10% on launch of COVID-19 test seekingalpha.com Sep 3, 2020 8:25 pm NIH begs to differ on FDA's EUA for convalescent plasma for COVID-19 seekingalpha.com Sep 2, 2020 3:48 am
ADMA Biologics Provides Regulatory Update on BIVIGAMĀ® PAS Submissions finance.yahoo.com Aug 13, 2020 5:58 pm
ADMA Biologics Reports Third Quarter 2018 Financial Results finance.yahoo.com Aug 13, 2020 5:05 pm
ADMA Biologics Reports First Quarter 2019 Financial Results finance.yahoo.com Aug 13, 2020 4:18 pm ADMA Biologics' stock rockets on heavy volume after FDA approval of immunodeficiency treatment marketwatch.com Aug 6, 2020 9:00 am FDA to fast-track COVID-19 vaccine - Financial Times seekingalpha.com Aug 31, 2020 12:57 pm Does convalescent plasma help COVID-19 patients? Studies will answer seekingalpha.com Aug 29, 2020 2:00 pm Convalescent plasma players rally on FDA emergency use nod seekingalpha.com Aug 24, 2020 6:22 pm FDA allows emergency use of convalescent plasma to treat COVID-19 seekingalpha.com Aug 24, 2020 6:39 am Convalescent plasma players under pressure on FDA hold on emergency use nod seekingalpha.com Aug 19, 2020 9:39 pm Convalescent plasma players rally on positive results from COVID-19 study seekingalpha.com Aug 14, 2020 3:45 am
ADMA Biologics Reports Business Highlights and Second Quarter 2020 Financial Results finance.yahoo.com Aug 13, 2020 4:05 pm
ADMA Biologics Rips Higher On FDA Nod For Immunodeficiency Therapy finance.yahoo.com Aug 13, 2020 10:26 am
How Many ADMA Biologics, Inc. (NASDAQ:ADMA) Shares Did Insiders Buy, In The Last Year? finance.yahoo.com Aug 13, 2020 9:28 am
CoVIg-19 Plasma Alliance Builds Strong Momentum Through Expanded Membership and Clinical Trial Collaboration finance.yahoo.com Aug 13, 2020 8:42 am
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors finance.yahoo.com Aug 13, 2020 7:38 am
The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial finance.yahoo.com Aug 13, 2020 7:30 am
ADMA Biologics Announces Martha J. Demski Elected to Board of Directors finance.yahoo.com Aug 13, 2020 7:00 am Talk about ADMA Biologics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. This profile is based on publicly available information and is intended to be informative in nature. Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
If you want to help pay for server cost or for improving this tool. You can send it via Paypal . More features coming soon :)
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written. -- Warren Buffet